EurekAlert! -
4 Mar 2021 07:00
(University of Houston) Of those diagnosed with a "spongy heart," 47% will die. University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for the heart disease officially called left ventricular non-compaction cardiomyopathy (LVNC).
Share this Article